Name | SARS-CoV-2 3CLpro-IN-7 |
---|
Description | SARS-CoV-2 3CLpro-IN-7 is a reversible covalent SARS-CoV-2 3CL protease inhibitor with an IC50 value of 1.4 µM[1]. |
---|---|
Related Catalog | |
In Vitro | SARS-CoV-2 3CLpro-IN-7 (0-100 µM; 5, 30, 60, 180 min) 以剂量和时间依赖性方式抑制 SARS-CoV-2 3CLpro 活性 [1]。 |
References |
Molecular Formula | C24H17ClN2O6 |
---|---|
Molecular Weight | 464.85 |